The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

The machines, which cost six figures and are used during heart surgery, will now have to be repaired by the company directly.

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...

The healthcare industry is in a transformative period. At the center of this change are the medical device companies of Northern Kentucky.

From medical devices to OTC drugs, preemption to expert preclusion, New York state and federal courts issued decisions in ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...